Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 73,710 | 59,753 | 54,733 | 46,988 | 62,782 |
| Cost of Goods | 19,288 | 16,826 | 18,470 | 16,491 | 29,544 |
| Gross Profit | 54,422 | 42,927 | 36,263 | 30,497 | 33,238 |
| Operating Expenses | 60,833 | 64,472 | 90,661 | 56,194 | 57,958 |
| Operating Income | -6,123 | -20,719 | -53,928 | -25,206 | -24,176 |
| Interest Expense | 0 | 0 | 3,105 | 864 | 67 |
| Other Income | 2,366 | -4,062 | 25,441 | 718 | -89 |
| Pre-tax Income | -3,757 | -24,781 | -31,592 | -25,352 | -24,332 |
| Income Tax | -2,417 | -37,286 | 1,634 | -3,774 | 146 |
| Net Income Continuous | -1,340 | 12,505 | -33,226 | -21,578 | -24,478 |
| Net Income Discontinuous | -469 | 108,274 | 341 | -771 | N/A |
| Net Income | $-1,809 | $120,779 | $-32,885 | $-22,349 | $-24,478 |
| EPS Basic Total Ops | -0.07 | 4.65 | -1.38 | -1.00 | -1.12 |
| EPS Basic Continuous Ops | -0.05 | 0.48 | -1.40 | -0.97 | -1.12 |
| EPS Basic Discontinuous Ops | -0.02 | 4.17 | 0.01 | -0.03 | N/A |
| EPS Diluted Total Ops | -0.07 | 4.58 | -1.38 | -1.00 | -1.12 |
| EPS Diluted Continuous Ops | -0.05 | 0.47 | -1.40 | -0.97 | -1.12 |
| EPS Diluted Discontinuous Ops | -0.02 | 4.10 | 0.01 | -0.03 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.05 | 0.51 | -1.36 | -1.00 | -1.12 |
| EBITDA(a) | $-4,370 | $-16,649 | $-51,741 | $-24,274 | $-22,034 |